Study Shows Peritoneal Mesothelioma Surgery Underutilized

August 13, 2020 By Melissa Soria

The continued underutilization of aggressive surgery for peritoneal mesothelioma is shortening survival time dramatically for patients who could qualify for, and benefit from, the highly effective procedure. Only a third of those diagnosed with peritoneal mesothelioma are undergoing potentially curative cytoreductive mesothelioma surgery, according to a comprehensive study of the National Cancer Database by researchers at…

The Need for Consistent Testing Terminology in Oncological Precision Medicine

August 5, 2020 By Erika R. Whitehead

In July, a working group of 41 prestigious patient advocacy organizations, professional societies, pharmaceutical and diagnostic companies, and laboratories, provided recommendations to fellow healthcare officials for the adoption of consistent, plain language terms for biomarker and genetic testing. The goal of the research is to help eliminate patient confusion about precision testing terminology in oncology.…

Women With Cancer Awarded Billions in Baby Powder Suit

June 24, 2020 By Melissa Soria

A Missouri appeals court ordered Johnson & Johnson and a subsidiary to pay $2.1 billion in damages to women who blamed their ovarian cancers on the company’s talcum products, including its iconic baby powder. The decision slashed by more than half a record award of $4.69 billion in compensatory and punitive damages to the women,…

New study shows that mesothelioma therapies are underutilized in women

June 16, 2020 By Melissa Soria

A new study has found that #mesothelioma therapies are underutilized in women. A research team of specialists has uncovered a surprising underutilization of treatments for pleural mesothelioma cancer in women. Women were 15% less likely to receive aggressive mesothelioma surgery that has proven its worth in extending lives for this cancer, which has no definitive cure. They…

New liquid biopsy test unveiled for mesothelioma

February 18, 2020 By Melissa Soria

Cellular Analytics, a biotechnology company in Ontario, Canada, has unveiled a novel liquid biopsy test for mesothelioma that could lead to more effective management of this rare cancer. The test has the potential to produce a much-earlier diagnosis of disease and the ability to personalize treatment and better predict a patient’s response to specific therapies.…

Kellogg’s will phase out glyphosate

January 28, 2020 By Melissa Soria

Kellogg’s has set a goal of phasing out the controversial weedkiller #glyphosate (used in #Roundup) from its oat and wheat supply chain by 2025, the company confirmed this week. Kellogg’s Chief Sustainability Officer Amy Senter said the company has been working with suppliers on pesticide use since before 2017, and will “continue to actively monitor the science,…

Bayer discusses $10 billion settlement

January 27, 2020 By Melissa Soria

Bayer, which markets the weedkiller Roundup, is in talks to create what might become a $10 billion settlement of tens of thousands of lawsuits claiming that the product causes cancer, a media report says. The company said it would set aside $8 billion to resolve current cases and $2 billion for future claims. The news service…

BMJ Case Report Study

January 27, 2020 By Melissa Soria

According to a new study by the BMJ Case Reports, any length or type of exposure to asbestos can cause mesothelioma. No matter if you were exposed to a low quantity or just one instance of exposure, you could be at risk. The study analyzed the case of a pleural mesothelioma patient who had “remote, short-term asbestos…

Load more